HAVN Life Sciences Inc. (HAVLF) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Biotecnología industria. La empresa tiene su sede en Port Moody, BC, Canada. El CEO actual es Tim Moore.
HAVLF tiene fecha de IPO 2021-01-08, 6 empleados a tiempo completo, cotiza en el Other OTC, una capitalización de mercado de $2.57K.
HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.
